ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Xanthotoxol suppresses non-small cell lung cancer progression and might improve patients' prognosis

Lin, Xian; Liu, Jingfeng; Zou, Yujiao; Tao, Cheng; Chen, Jian*广东医学院; 北京大学; 南方医科大学
PHYTOMEDICINE2022-10DOI: 10.1016/j.phymed.2022.154364
10被引10阅读
引用收藏
分享

摘要

Background: Developing novel and effective drugs with less toxicity is urgent for non-small cell lung cancer (NSCLC) therapy. Xanthotoxol (Xan) is the major natural component of the medical plant Angelica dahurica with potential anti-cancer activities. @@@ Purpose: In this study, we aimed to demonstrate the effect and underlying mechanism of Xan in NSCLC and evaluate the effectiveness of Xan in NSCLC patients. @@@ Methods: CCK8, colony formation, EdU, flow cytometry, and transwell assays were carried out to investigate the anti-NSCLC activity of Xan in vitro. In addition, the xenograft mouse model was established to evaluate the anti-NSCLC effect of Xan in vivo. Moreover, bioinformatics analysis was performed to establish a prediction model based on RNA sequencing data. Furthermore, Western blot was used to detect the expression of proteins regulated by Xan. @@@ Results: Xan inhibited the cell viability, colony formation capacity, DNA replication, cell cycle transition, migration and invasion, as well as inducing apoptosis of NSCLC cells. In addition, Xan suppressed NSCLC xenograft growth in vivo without obvious toxicity. Interestingly, bioinformatics analyses based on the RNA sequencing data indicated that Xan exerted inhibitory effects on NSCLC cells by down-regulating signals contributing to NSCLC progression and demonstrated that Xan was effective in ameliorating the prognosis of NSCLC patients with a new proposed prediction model. Moreover, Xan was shown to regulate cell cycle arrest, apoptosis, and epithelial-mesenchymal transition (EMT)-associated genes through downregulating PI3K-AKT signaling, thus suppressing NSCLC proliferation and metastasis. @@@ Conclusions: Taken together, our work proved that Xan induced cell cycle arrest, facilitated apoptosis, and inhibited EMT processes through downregulating the PI3K-AKT pathway to suppress NSCLC progress. Moreover, we also proposed a new model for evaluating Xan as a novel and effective drug in NSCLC treatments.

学科与关键词

关键词
XanthotoxolPI3K-AKTBioinformaticsNon-small cell lung cancer
相关
加载中…
  • Xanthotoxol suppresses non-small cell lung cancer progression and might improve patients' prognosis (vol 105, 154364, 2022)
    Lin, Xian; Liu, Jingfeng; Zou, Yujiao; Tao, Cheng; Chen, Jian*PHYTOMEDICINE, 2023, 108: 154547.
  • Xanthatin synergizes with cisplatin to suppress homologous recombination through JAK2/STAT4/BARD1 axis in human NSCLC cells
    Zhang, Jian; Yang, Sheng; Guan, Hongmei; Zhou, Jueyu*; Gao, Yuan*Journal of Cellular and Molecular Medicine, 2021, 25(3): 1688-1699.被引 8
  • Systems biology strategy and experimental validation to uncover the pharmacological mechanism of Xihuang Pill in treating non-small cell lung cancer
    Zhuang, Zhenjie; Huang, Dan; Sheng, Zhou Rui; Jiang, Haimei; Ye, Zeng Jie; Yuan, Yi; Qin, Binyu; Zhao, Yan; Pan, Hua-Feng*; Tang, Ying*PHYTOMEDICINE, 2023, 108: 154491.被引 5
查看全部 →

发表信息

论文状态
公开发表
期刊
PHYTOMEDICINE
发表日期
2022-10
卷期
第 105 卷
页码
154364
DOI
10.1016/j.phymed.2022.154364
语言
GERMAN
期刊等级
2区
成果收录
SCIE
资助标注
China Postdoctoral Science Foundation [2021T140468, 2021M693290]; Guangdong Basic and Applied Basic Research Foundation [2021A1515111089, 2021A1515111000]; Natural Science Foundation of Shenzhen City [JCYJ20210324110209026]; Scientific Research Foundation of Peking University Shenzhen Hospital [KYQD202100X, KYQD2021034, KYQD2021054]; Discipline Construction Project of Guangdong Medical University [4SG22004G]; National Natural Science Foundation of China [81903116]; Shenzhen Key Laboratory of Inflammatory and Immunology Diseases [ZDSYS20200811143756018]; Funds for PHD researchers of Guangdong Medical University in 2022 [4SG22226G]

作者

  • L

    Lin, Xian (第一作者)

    hong kong univ sci & technol · peking univ · peking univ shenzhen

  • L

    Liu, Jingfeng

    hong kong univ sci & technol · peking univ · peking univ shenzhen

查看全部 5 位作者收起作者
  • Z

    Zou, Yujiao

    southern med univ

  • T

    Tao, Cheng

    guangdong med univ

  • C

    Chen, Jian (通讯)

    peking univ · hong kong univ sci & technol · peking univ shenzhen

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417